RadNet, Inc. filings document material-event disclosures for operating results, financial condition, governance, capital structure, and corporate actions tied to its diagnostic imaging and digital health businesses. Recent Form 8-K reports furnish quarterly results press releases and exhibits, including segment information for Imaging Centers and Digital Health.
The company’s proxy materials address board matters, executive compensation, and shareholder voting items. Other filings include leadership and compensatory-arrangement disclosures, prospectus supplements under automatic shelf registration statements for common stock resale registrations, and acquisition-related share issuance matters associated with RadNet’s health informatics expansion.
RadNet, Inc. (RDNT) Form 4: Mark Stolper, EVP and Chief Financial Officer, reported a sale of Common Stock on 09/16/2025. He disposed of 35,000 shares at a weighted-average price of $73.89, with individual trade prices ranging from $73.51 to $74.57. Following the reported disposition, he beneficially owned 68,012 shares, held directly. The Form 4 was filed as an individual report and signed by an attorney-in-fact on 09/18/2025.
RadNet, Inc. (RDNT) Form 4: Mark Stolper, EVP and Chief Financial Officer, reported a sale of Common Stock on 09/16/2025. He disposed of 35,000 shares at a weighted-average price of $73.89, with individual trade prices ranging from $73.51 to $74.57. Following the reported disposition, he beneficially owned 68,012 shares, held directly. The Form 4 was filed as an individual report and signed by an attorney-in-fact on 09/18/2025.
David Jeffrey Katz, EVP and Chief Legal Officer of RadNet, Inc. (RDNT), reported a sale of 14,000 shares of RadNet common stock on 09/16/2025 at a price of $74.44 per share. Following the transaction he beneficially owned 68,181 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/17/2025. The filing records a routine insider disposition and provides share counts and transaction price.
RadNet, Inc. (RDNT) Form 144 notice reports a proposed sale of 14,000 common shares, scheduled approximately for 09/16/2025 through The Charles Schwab Corporation on Nasdaq with an aggregate market value of $1,049,860.00. The securities were acquired as a stock award on 01/04/2023 and the filer lists 14,000 shares available for sale against a public float of 76,916,062 shares outstanding. The filing also discloses a sale of 17,000 shares on 08/13/2025 for gross proceeds of $1,161,270.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer. Certain issuer contact fields and the filer relationship to the issuer are not specified in the provided content.
Form 144 notice for RadNet, Inc. (RDNT): The filer notified the SEC of a proposed sale of 35,000 common shares on 09/15/2025 through Merrill Lynch (Chandler, AZ) on NASDAQ, with an aggregate market value of $2,590,350.00. The shares were acquired as equity compensation in multiple grants dated between 01/02/2014 and 01/03/2017, totaling listed lots of 8,353; 12,018; 12,982; 1,638; and 9 shares. The filer reports no securities sold in the past three months for the account. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
RadNet, Inc. (RDNT) director/officer Wesdorp Cornelis reported a sale of company common stock. The Form 4 shows a transaction on 09/11/2025 in which 500 shares were sold at $72.13, leaving Mr. Wesdorp with 53,495 shares beneficially owned in a direct ownership form. The filing was signed by an attorney-in-fact, Jose Gamez, on 09/12/2025.
Form 144 notice for RadNet, Inc. (RDNT) shows a proposed sale of 500 shares of common stock through APEX Clearing on 09/11/2025. The shares were acquired by the seller as compensation on 10/01/2024. The filing reports an aggregate market value of $36,865 for the proposed sale and lists 76,916,062 shares outstanding for the class.
The notice also discloses recent sales by the same person: 1,500 shares sold on 08/19/2025 for $100,470 and 500 shares sold on 09/09/2025 for $35,995. The filer certifies they are not aware of undisclosed material adverse information about the issuer and includes the standard Rule 144 representations and warnings about intentional misstatements.
RadNet, Inc. (RDNT) notice: an individual plans to sell 10,000 common shares through Raymond James on 09/10/2025 on NASDAQ for an aggregate market value of $726,892.00. The shares were originally acquired as restricted stock units on 05/02/2017 and paid for in cash. The filer reports 76,916,062 shares outstanding for the class and discloses no sales by the seller in the past three months. The form includes the standard representation that the seller is not aware of undisclosed material adverse information and the required signature/notice language.
On 09/09/2025, Cornelis Wesdorp, President & CEO, Digital Health at RadNet, Inc. (RDNT) reported a sale of 500 shares of the issuer's common stock at a price of $71.99 per share. After this transaction Wesdorp beneficially owned 53,995 shares directly. The Form 4 was signed by an attorney-in-fact on 09/10/2025. No derivative transactions or additional explanatory details were provided.
Form 144 notice for RadNet, Inc. (RDNT) reporting a proposed sale of 2,000 common shares through APEX Clearing valued at $145,460. The filing shows approximate sale date 08/19/2025 and reports 76,916,062 shares outstanding. The 2,000 shares were acquired from the issuer on 10/01/2024 as compensation (1,500 and 500 units recorded separately). The filing also records a sale on 08/19/2025 by Cornelis Wesdorp of 1,500 shares for $100,470. The notice includes the required representation that the seller is not aware of undisclosed material adverse information and contains the standard signature and legal attestation language.
RadNet insider sale: On 08/27/2025, Norman R. Hames, President and COO - West Operations, reported selling 5,000 shares of RadNet, Inc. common stock at $71.10 per share. After the transaction he is reported to beneficially own 19,889 shares indirectly through his spouse. The Form 4 was signed by an attorney-in-fact on 08/29/2025 and contains no derivative transactions or additional amendments.